NEAR Protocol reached 1 million transactions per second in benchmark tests using 70 shards, demonstrating sharding's scalability potential far beyond Visa's peak capacity. The post NEAR Achieves 1M Transactions Per Second in Sharded, Test Environment appeared first on Coinspeaker.NEAR Protocol reached 1 million transactions per second in benchmark tests using 70 shards, demonstrating sharding's scalability potential far beyond Visa's peak capacity. The post NEAR Achieves 1M Transactions Per Second in Sharded, Test Environment appeared first on Coinspeaker.

NEAR Achieves 1M Transactions Per Second in Sharded, Test Environment

NEAR Protocol NEAR $1.75 24h volatility: 1.1% Market cap: $2.24 B Vol. 24h: $188.81 M has achieved a significant milestone of 1 million transactions per second (TPS) in a benchmark test environment created to simulate a real-world scenario. This development helps to demonstrate sharding is an efficient method for high scalability and throughput capacity for high-performance blockchains—surpassing Visa’s peak capacity of around 65,000 transactions per second.

The NEAR Foundation reported this recent achievement in a blog post on Dec. 8, explaining the benchmark’s methodology in “a publicly verifiable benchmark using real code, realistic workloads, and cost-effective and performant Google Compute Engine C4D machines across 70 shards,” as described.

Results are available in three Grafana dashboards that achieved 1,029,497, 1,037,334, and 1,037,495 transactions per second peaks, followed by a constant one million TPS performance for nearly one hour each.

Grafana dashboards for three NEAR Protocol 1M-TPS tests | Source: NEAR Foundation/Grafana

Grafana dashboards for three NEAR Protocol 1M-TPS tests | Source: NEAR Foundation/Grafana

As described in the blog post, this benchmark had validators split in 70 shards, running commercial-grade hardware from Google Cloud, with an approximate cost of $900 per month. While accessible, this cost is significantly higher than the minimum required to run chunk validators on NEAR—currently estimated at $15 per month, according to Meta Pool’s Node Studio.

This test used only native token transfers, not broadcasting smart contract executions that require more network gas and computational power, which could reduce the overall capacity per second. Moreover, the NEAR blockchain currently has nine shards and not the 70 shards used for the tests, meaning the current mainnet capacity is likely orders of magnitude below the achieved one million transactions per second.

Nevertheless, it suggests NEAR Protocol is ready, with enough optimizations, to scale at any moment to something close to 1 million TPS with consistency and network reliability as adoptions and demand for block space grows.

How Many TPS Other Blockchains and Payment Processors Can Achieve?

Interestingly, Visa (NYSE: V) can scale to 65,000 transactions per second, according to The Banking Scene. In 2024, Visa processed an average of approximately 25,091 transactions per second globally, based on the total of roughly 293 billion payment transactions handled that year.

Data Coinspeaker gathered from Chainspect on Dec. 8 shows the theoretical maximum TPS other blockchains can achieve, based on benchmark tests like the one provided by NEAR, or rough calculations by the Chainspect analysts.

When comparing with some of the largest cryptocurrencies by market cap, Sonic, ICP, and Aptos have the largest maximum theoretical TPS after NEAR, with nearly 400,000, 210,000, and 160,000 transactions per second, respectively.

Sui SUI $1.61 24h volatility: 0.9% Market cap: $6.01 B Vol. 24h: $995.44 M , TON TON $1.63 24h volatility: 1.4% Market cap: $3.98 B Vol. 24h: $135.10 M , Polkadot DOT $2.12 24h volatility: 0.7% Market cap: $3.49 B Vol. 24h: $192.42 M , and Solana SOL $134.4 24h volatility: 1.0% Market cap: $75.38 B Vol. 24h: $5.34 B follow suit, with approximately 120,000, 105,000, 100,000, and 65,000 TPS, respectively. However, SOL is the one with the highest “Real-Time TPS” across all blockchains on Chainspect—at 1,238 transactions per second by the time of this writing.

Fastest blockchains by transactions per second (TPS), as of Dec. 8 | Source: Coinspect

Fastest blockchains by transactions per second (TPS), as of Dec. 8 | Source: Coinspect

Therefore, this recent achievement positions NEAR as one of the layer-one blockchain networks with the highest theoretical capacity and scalability. This adds up to recent positive developments in the NEAR ecosystem, as Coinspeaker has covered and reported about.

On Dec. 5, NEAR launched TravAI, together with ADI Chain, where AI agents handle complete travel booking workflows from search to payment using crypto. On Dec. 3, the foundation announced NEAR AI Cloud and Private Chat, two related products that were already integrated by relevant players like the Brave Browser. Kalshi also recently added support to NEAR’s native token and NEAR Intents surpassed the $7 billion mark for its chain-abstracted swaps all-time volume.

next

The post NEAR Achieves 1M Transactions Per Second in Sharded, Test Environment appeared first on Coinspeaker.

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.52
$1.52$1.52
+0.52%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26